Search research articles
Contact Us
Filters
Showing results (91-100 of 140) with videos related to
Page
of 14
Sort By:
Cytokine & Growth Factor Reviews
|
October 15, 2017
Innovative Therapy, Monoclonal Antibodies and Beyond
M Di Nicola, L Apetoh, M Bellone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2009
Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours
C Sessa, S Cresta, C Noberasco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 4, 2004
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
D I Jodrell, T R J Evans, W Steward, et al.
The Pharmacogenomics Journal
|
November 11, 2009
Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer
F Toffalorio, E Giovannetti, T De Pas, et al.
Breast Cancer Research and Treatment
|
September 27, 2005
Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery
G Curigliano, J Y Petit, F Bertolini, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 16, 2013
Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy
E Seregni, M Maccauro, C Chiesa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2014
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
F Pietrantonio, F Perrone, F de Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program
S Brienza, M A Bensmaïne, P Soulié, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 27, 2010
A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma
Chiara Catania, G Pelosi, N Fazio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2009
Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer
G Spitaleri, D V Matei, G Curigliano, et al.
Page
of 14
Search research articles
Search
Showing results (91-100 of 140) with videos related to
Sort By:
Page
of 14
Cytokine & Growth Factor Reviews
|
October 15, 2017
Innovative Therapy, Monoclonal Antibodies and Beyond
M Di Nicola, L Apetoh, M Bellone, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 8, 2009
Phase I clinical and pharmacokinetic study of trabectedin and cisplatin in solid tumours
C Sessa, S Cresta, C Noberasco, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 4, 2004
Phase II studies of BBR3464, a novel tri-nuclear platinum complex, in patients with gastric or gastro-oesophageal adenocarcinoma
D I Jodrell, T R J Evans, W Steward, et al.
The Pharmacogenomics Journal
|
November 11, 2009
Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer
F Toffalorio, E Giovannetti, T De Pas, et al.
Breast Cancer Research and Treatment
|
September 27, 2005
Systemic effects of surgery: quantitative analysis of circulating basic fibroblast growth factor (bFGF), Vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGF-beta) in patients with breast cancer who underwent limited or extended surgery
G Curigliano, J Y Petit, F Bertolini, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 16, 2013
Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy
E Seregni, M Maccauro, C Chiesa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 2014
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation
F Pietrantonio, F Perrone, F de Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 13, 2000
Oxaliplatin added to 5-fluorouracil-based therapy (5-FU +/- FA) in the treatment of 5-FU-pretreated patients with advanced colorectal carcinoma (ACRC): results from the European compassionate-use program
S Brienza, M A Bensmaïne, P Soulié, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 27, 2010
A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma
Chiara Catania, G Pelosi, N Fazio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 14, 2009
Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer
G Spitaleri, D V Matei, G Curigliano, et al.
Page
of 14